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Background: Discordant lymphoma is defined by the simultaneous presence of two or more distinct types of
lymphomas at different anatomic sites. With fewer than 20 studies reporting cases of discordant lymphoma to date,
the incidence of this condition is believed to be very low.
Case Presentation: Here, we report a case of discordant lymphoma in a 34-year-old female patient that involved
mediastinal large B-cell lymphoma and nodular sclerosis Hodgkin lymphoma in the right supraclavicular lymph
nodes. The patient presented with a mass in the mediastinum and enlargement of the right supraclavicular lymph
nodes, but no obvious signs of lymphoma. Histological examination revealed that the encapsulated mediastinal
mass contained medium- or large-size tumor cells with lightly stained cytoplasm and round vesicular nuclei as well
as a high percentage of mitotic cells; strongly positive immunohistochemical staining for PAX5, CD20, and CD79a
also was observed. Examination of biopsied right supraclavicular lymph node tissues revealed separation by
collagen fibers, extensive inflammatory cell infiltration, and large-size tumor cells, such as Reed–Sternberg cells.
These tissues stained strongly positive for PAX5 and CD30, weakly positive for CD15, and negative for Epstein-Barr
viral RNA. We also found monoclonal gene rearrangement in the immunoglobulin heavy chain gene in the
mediastinal large B-cell lymphoma, but no monoclonal gene rearrangement in the nodular sclerosis Hodgkin
lymphoma. These findings suggested that these two lymphomas were not of a common clonal origin. The patient
was treated by surgical excision of the mediastinal mass followed by radio-chemotherapy, and no metastasis or
recurrence occurred during a follow-up period of 32 months.
Conclusion: A review of previously reported cases indicated that the clinical manifestations and pathological
features of discordant lymphoma are diverse due to variation in the types of lymphomas involved. Physicians must
have an awareness of discordant lymphoma to avoid incorrect and missed diagnoses, especially considering that
the true incidence may not be as low as previously believed.
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Malignant lymphomas (MLs) originate from aberrant
monoclonal lymphocyte proliferation resulting from an
interference with normal differentiation and ineffective
control of growth. MLs usually involve a single histo-
logical type that remains unchanged during cancer de-
velopment and progression, and the same type of ML
can occur at different anatomic sites. A rarer condition
known as composite lymphoma is defined by the pres-
ence of different types of MLs found at the same ana-
tomic site [1], and an even rarer condition known as
discordant lymphoma is defined by the presence of dif-
ferent ML types located at different anatomic sites [2].
The incidence of discordant lymphoma is believed to
be very low, with fewer than 20 papers reporting
cases of discordant lymphomas in the current litera-
ture. However, as we will discuss, some studies sug-
gest the incidence many be higher than believed. A
variety of non-Hodgkin lymphomas, Hodgkin lymph-
omas, and combinations of non-Hodgkin lymphoma
and Hodgkin lymphoma have been observed in dis-
cordant lymphoma cases reported to date. Moreover,
the coexistence of lymphoma and other malignant tu-
mors also has been reported [3]. Among the combi-
nations of non-Hodgkin lymphoma and Hodgkin
lymphoma, several cases of B cell lymphomas and
Hodgkin lymophoma combinations have been re-
ported [4–6]. However, in most cases, the second
tumor occurs after the treatment of the first one. It is
rare that B cell lymphomas and Hodgkin lymophoma
occur synchronously in discordant lymphoma. Here,
we present a case of discordant lymphoma involving
B cell lymphoma and Hodgkin lymphoma. To the
best of our knowledge, this is the first reported case
of simultaneous large B-cell lymphoma in the medias-
tinum and nodular sclerosis Hodgkin lymphoma in
the right supraclavicular lymph nodes.Fig. 1 Representative images from ultrasound and CT examinations. a Ultra
supraclavicular lymph node. b CT scanning revealed an irregular soft tissue
suppression of the superior vena cava by the massCase Presentation
A 34-year-old female patient was admitted to our hospital
after a mass in the mediastinum was identified during a
routine heath check-up. The patient reported no recent
history of symptoms such as fever, chest pain, coughing,
weight loss, or edema. The results of peripheral blood
tests were all within the normal ranges. Multiple enlarged
lymph nodes were identified at the right clavicle by palpa-
tion. Ultrasound examination showed multiple hypoe-
choic nodules (maximum size of 2.25 cm× 1.23 cm) on
the right supraclavicular lymph nodes (Fig. 1a). Chest
computed tomography (CT) examination showed an ir-
regular soft tissue mass (6.2 cm × 3.7 cm) with a clear
border in the mediastinum, and the superior vena cava
was compressed by the mass (Fig. 1b). Pleural thickening
and effusion were not observed. The mediastinal tumor
and one of the affected right supraclavicular lymph nodes
were surgically excised and pathologically examined.
Grossly, the mediastinal tumor was an encapsulated
grayish-brown mass (7.5 cm × 6 cm × 4.5 cm) that did
not exhibit bleeding or necrosis. The cut surface of the
tumor revealed yellow and raw fish-like tissue. The tu-
mors in the right supraclavicular lymph nodes were pale,
bean-shaped nodules, and the cut surfaces of the tumors
showed pale, solid tissue.
The excised tumors were characterized by histopatho-
logical examination. After fixation in 10 % neutral for-
maldehyde, the specimens were dehydrated in a graded
series of ethanol solutions and embedded in paraffin for
sectioning at 4 μm thickness. Histological examination
via hematoxylin and eosin (HE) staining revealed that
the encapsulated mediastinal tumor consisted of large
nodules separated by thin fibrous tissues. Tumor cells
(medium- or large-size) with lightly stained cytoplasm
and heavily stained or bubbly nuclei were diffusely dis-
tributed throughout the tumor (Fig. 2a), and many small
lymphocytes formed a perivascular "angiolymphoid set"sound examination showed multiple hypoechoic nodules in the right
mass (6.2 cm × 3.7 cm) with a clear border in the mediastinum and
Fig. 2 Histologic features of lymphomas observed via H&E staining. a Diffuse distribution of tumor cells (medium- or large-size) with lightly stained
cytoplasm and heavily stained or bubbly nuclei was observed in the mediastinal mass (×200). b Large amounts of small lymphocytes formed
a perivascular "angiolymphoid set" in the mediastinal tumor tissue (×200). c Mitosis was observed frequently in the mediastinal tumor cells (×400).
d The right supraclavicular lymph node tissue was separated into nodules of varying size by refractive collagen fibers (×40). e Large tumor cells of
varying size and distribution were scattered throughout the lymph node tissue (×200). f Lacunar cells were observed in lymph node sections (×400)
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were observed frequently in the round or slightly irregu-
lar nuclei of tumor cells (Fig. 2c). In addition, residual
thymic epithelial cells were observed in the encapsulated
mediastinal tumor. Histological staining showed that the
right supraclavicular lymph node tissue was separated
into nodules of varying size by refractive collagen fibers
and large tumor cells (mostly lacunar cells and a small
amount of Reed-Sternberg cells, popcorn cells, and
mummy cells) were scattered throughout the lymph
node tissue (Fig. 2d–f ). Some areas of necrosis were ob-
served in the lymph node tissue, which was related to
the infiltration of a large amount of inflammatory cells
including small lymphocytes, eosinophils, plasma cells,
and histiocytes.
Tumor tissues also were examined using an immu-
nohistochemistry (IHC) assay (EnVision™ two-stepimmunohistochemical technique) to determine the
histological types of the tumors (Table 1). The antibodies
(anti- PAX5, anti-CD20, anti-CD3, anti-CD5, anti-CD45,
anti-CD79a, anti-CD10, anti- EMA, anti-CD57, anti-
CD23, anti-CD30, anti- BCL-2, anti-CK, anti-CD21, anti-
CD15, anti- MUM1, anti-BCL-6, and anti-Ki-67) used in
the IHC assay were purchased from Zhongshan Golden
Bridge, Inc. (Beijing, China). Cells within the encapsulated
mediastinal tumor stained strongly positive (+++) for
CD45 and CD79a (Fig. 3a), PAX5 (Fig. 3b), and CD20, and
positive (+) for BCL-2 and MUM1. In addition, approxi-
mately 80% of the mediastinal tumor cells were positive
(+) for Ki-67 (Fig. 3c). Small lymphocytes were positive (+)
for CD3, and residual thymic epithelial cells were positive
(+) for CK. In the right supraclavicular lymph node speci-
men, tumors cells stained strongly positive (+++) for
CD30 (Fig. 3d), weakly positive (+) for CD15 (Fig. 3e), and
Table 1 Immunohistochemical staining results for the excised
mediastinal mass and supraclavicular lymph nodes









CD3 - + - +++
CD5 - - - +
CD10 - - - -
CD15 - - + -
CD20 +++ - - ++
CD21 - - - -
CD23 - - - +
CD30 - - +++ -
CD45 +++ - - +++
CD57 - - - +
CD79a +++ - - ++
Bcl-2 + - - -
Bcl-6 - - - -
CK - - - -
EMA - - - -
MUM1 + - - -
PAX5 +++ - - -
Ki67 80% + - 60% + -
EBER - - - -
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in the lymph node tissue were positive for Ki-67 (Fig. 3f).
Small lymphocytes were strongly positive (+++) for CD3
and CD45, moderately positive (++) for CD79a and CD20,
and weakly positively (+) for CD57, CD5, and CD23.
Gene rearrangements and clonality analysis of im-
munoglobulin heavy chain gene, Kappa light chain gene,
and Lambda light chain gene were identified in our case
using the IdentiCloneTM IGH/IGK/IGL Gene Clonality
Assay (InVivoScribe Technologies, CA, USA). The lacu-
nar cells in nodular sclerosis Hodgkin lymphoma and
the tumor cells in mediastinal large B-cell lymphoma
micro-manipulated from tissues were subjected to
single-cell PCR. Monoclonal gene rearrangement was
observed in mediastinal large B cell lymphoma as two
discrete bands appearing within 240–300 base pairs (bp)
and 300–360 bp in the immunoglobulin heavy chain
gene, but no monoclonal gene rearrangement was ob-
served in nodular sclerosis Hodgkin lymphoma in the
right supraclavicular lymph nodes (Additional file 1).
Moreover, in our case, the EB virus-encoded small RNA
(EBER) was used to design a single-stranded RNA probe
for in situ hybridization (ISH) detection of Epstein-Barr
(EB) virus (TIB Biosicences, Fuzhou, China). Nasopha-
ryngeal cancer samples positive for EB virus RNA were
used as a positive control in ISH experiments. Tissuesamples from both the mediastinal tumor and a right
supraclavicular lymph node were negative (−) for EB
virus RNA.
Together these morphological, histopathological, and
immunohistochemical observations as well as gene identi-
fication results, supported the diagnosis of discordant
lymphoma consisting of mediastinal large B-cell lymph-
oma and nodular sclerosis Hodgkin lymphoma in the right
supraclavicular lymph nodes. After surgical removal and
evaluation of the mediastinal tumor and one right supra-
clavicular lymph node, iodine125 radiation particles were
implanted in the remaining right supraclavicular lymph
nodes, and the patient received six cycles of ABVD (doxo-
rubicin [Adriamycin] + bleomycin + vinblastine + dacarba-
zine) chemotherapy. No metastasis or recurrence was
observed during 32 months of follow-up examinations,
suggesting that the treatment was successful.
Discussion
As well as simultaneously presenting with other carcin-
omas [3], lymphomas can occur with other lymphomas
at the same site or at different sites. The incidences of
both composite lymphoma and discordant lymphoma
are believed to very low. Composite lymphoma was first
described by Custer in 1954 [1], and in the 60 years that
have followed, the number of reported cases of composite
lymphoma has steadily increased. However, discordant
lymphoma cases have been reported in fewer than 20 pa-
pers to date, suggesting that the incidence of discordant
lymphoma is lower than that of composite lymphoma.
However, interestingly, Kim and Dorfman identified six (7
%) cases of discordant lymphomas among 84 untreated
lymphoma patients [2]. In addition, Tucci et al. reported
that 45 (13 %) of 347 lymphoma patients had multiple
histological types of lymphomas, and 15 patients exhibited
discordant lymphoma [7]. Considering the incidence of
discordant lymphoma in these patient populations, it is
possible that the overall incidence of discordant lymph-
oma may not be as low as previously believed. Based on
the possible underestimation of the incidence of discord-
ant lymphoma, clinical identification of one tumor may
lead physicians to not continue searching for tumors at
other sites. In some cases, discordant lymphoma patients
have had no symptoms, such as the patient in the present
case. The lack of symptoms can lead to missed diagnosis.
These reasons may help to explain the low incidence of
discordant lymphoma in the current literature.
As another consequence of the small number of cases
reported in the literature, the pathogenesis of discordant
lymphoma remains incompletely understood. The occur-
rence of discordant lymphoma may be an accidental
phenomenon. Moreover, for cases of discordant lymph-
oma resulting from metachronous occurrence of different
types of lymphomas, it seems plausible that a lymphoma
Fig. 3 Expression of marker proteins for specific lymphoma types as determined by immunohistochemical staining. a CD79a in mediastinal tumor
tissue (×200); b PAX5 in mediastinal tumor tissue (×200); c Ki67 in mediastinal tumor tissue (×200); d CD30 in the right supraclavicular lymph
node tissue (×200); e CD15 in the right supraclavicular lymph node tissue (×200); f Ki67 in the right supraclavicular lymph node tissue (×200)
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which could increase the risk of another lymphoma occur-
ring at another site [6]. In addition, EB virus has been
shown to cause both Hodgkin lymphoma and non-
Hodgkin lymphoma in the same patients [8], and both
Hodgkin lymphoma and non-Hodgkin lymphoma at dif-
ferent sites were observed in HIV-positive patients [9].
However, no EB virus RNA was detected in the tumor tis-
sues in the present case, indicating that EB virus was not
involved in the development of the lymphomas in this
case. Furthermore, it has been reported that anti-
tumor therapy against a first lymphoma increases the
incidence of a second lymphoma due to the toxic ef-
fects of anti-tumor treatments, which can lead to dis-
cordant lymphoma [5, 8]. However, Van den Tweel
et al. presented an inconsistent view with the sugges-
tion that discordant lymphomas originate from the
same lymphocytes but exhibit different morphologies
at different stages [10].Although few in number, the previous reports of dis-
cordant lymphoma cases illustrate that the histological
types of tumors present in cases of discordant lymph-
omas can be very diverse. Examples of previously re-
ported discordant lymphoma cases are listed in Table 2.
Hodgkin lymphomas and non-Hodgkin lymphomas have
been the most commonly reported histological types in
discordant lymphomas [4, 11, 12]. Among these combi-
nations, several cases of B cell lymphomas and Hodgkin
lymophoma combinations were reported previously. In
addition, one study revealed that a B-cell lymphoma
may be present at one site and a T-cell lymphoma at an-
other site [13], while other studies demonstrated that
different B-cell lymphomas may be present at multiple
sites [14, 15]. Moreover, a variety of lymphoma types can
occur either synchronously or metachronously at differ-
ent sites. But, it is difficult though to determine clinically
whether lymphomas at different sites occur synchron-
ously or metachronously. The patient in our case was
Table 2 Cases of discordant lymphoma reported from 2000 to 2015 and the current case
no./Sex/Age Lacation Diagnosis Therapy Outcome Ref.
1/F/52 Inguinal LN HL ABVD CR 5
Nasopharyngeal B cell NHL NA NA
2/M/44 Intraabdominal mass FL chemotherapy CR 6
Cervical LN HL NA NA
3/F/67 Submandibular LN HL ABVD CR 8
Skin PTCL CHOP Died
4/M/32 Postcervical LN HL ABVD CR 11
Submandibular LN PTCL Autologous PBSCT NA
5/M/60 Inguinal LN PTCL Autologous PBSCT NA 11
Cervical LN HL CHOP Recurrence
6/M/40 Inguinal LN HL EVA CR 11
Cervical LN HL EVA CR
Subcarinal LN ALCL NA Died
7/F/77 Cervical LN PTCL CHOP Recurrence 11
Skin Necrotic T-cell NHL NA NA
8/M/37 Cervical LN PTCL IVAM, BEAM Autologous PBSCT Recurrence 12
Supraclavicular, HL ABVD Died
Inguinal, et al.
9/M/55 Cervical LN DLBCL Chemotherapy Died 13
Bone marrow PTCL CHOP Died
10/F/50 Stomach MALT NA NA 14
Parotied gland FL NA NA
11/M/70 Skin FL NA NA 15
LN MCL NA NA
12/F/34 Supraclavicular LN HL Iodine 125 radiation CR present
Mediastinum DLBCL ABVD CR study
LN lymph node; CR complete remission; NA not available; PTCL peripheral T-cell lymphoma; HL Hodgkin lymphoma; ALCL anaplastic large cell lymphoma; NHL
non-Hodgkin lymphoma; MALT mucosa-associated lymphoid tissue; FL follicular lymphoma; MCL mantle cell lymphoma; MZL marginal zone lymphoma; PBSCT
peripheral blood stem cell transplant; ABVD doxorubicin (Adriamycin), bleomycin, vinblastine, dacarbazine; CHOP cyclophosphamide, doxorubicin, vincristine
(Oncovin), prednisone; EVA etoposide, vinblastine, Adriamycin; IVAM ifosfamide, etoposide, cytarabine, methotrexate; BEAM bendamustine, etoposide,
cytarabine, melphalan
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ical history. Therefore, we speculate that the two lymph-
oma types occurred synchronously.
We now have confirmation that Hodgkin lymphoma
originates from B cells. Previous reports indicated the
possibility of transformation between B cell lymphomas
and Hodgkin lymphomas, including that large B cell
lymphomas can transform into Hodgkin lymphomas or
Hodgkin lymphomas can transform into large B cell
lymphomas [16]. In most cases of discordant lymphoma
with B cell lymphomas and Hodgkin lymophoma combi-
nations, the second tumor occurs after the treatment of
the first one. It is suspected that the transformation be-
tween these two lymphomas was induced by the treat-
ment and both tumors may have originated from the
same cell line. This speculation was confirmed in the
study by Nakamura et al. [6], who performed polymerasechain reaction (PCR) amplification of the bcl-2 and IgH
genes and then demonstrated the common clonal origin
of follicular lymphoma and subsequent Hodgkin lymph-
omas. Large B-cell lymphoma and Hodgkin lymphoma
originate from the same cell type (B cells). However,
these two tumors in the spectrum of B-cell lymphomas
have completely different morphological features and
immunophenotypes, and they belong to two separate
neoplasms. Thus, they are clearly distinguished and
named in the WHO classification of lymphoid tissues
[17]. However, Rosenwald et al. [18] used gene expres-
sion profiling to suggest over one third of the genes that
were more highly expressed in PMBL than in other
DLBCLs were also characteristically expressed in Hodgkin
lymphoma cells. In this case, patient had no obvious symp-
toms or the history of anti-tumor treatment. One tumor in
the mediastinum presented the typical morphology and
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other one in the right supraclavicular lymph nodes pre-
sented the typical morphology and phenotypic features of
nodular sclerosis Hodgkin lymphoma, consistent with the
obervastion that EBER-1 RNA ISH failed to stain in both
lymphomas. Furthermore, we determined the gene rear-
rangements and performed a clonality analysis of the im-
munoglobulin heavy chain gene, Kappa light chain gene,
and Lambda light chain gene and demonstrated monoclo-
nal gene rearrangement in the immunoglobulin heavy
chain gene in mediastinal large B-cell lymphoma. In
contrast, no monoclonal gene rearrangement was ob-
served in nodular sclerosis Hodgkin lymphoma in the
right supraclavicular lymph nodes. These findings sug-
gest that these two lymphomas were not of a com-
mon clonal origin. Consequently, the diagnosis was
definitive for both tumors according to medical his-
tory, histopathological, immunohistochemical observa-
tions, and gene identification.
Cases of discordant lymphoma are more complicated
and difficult to treat than those involving a single tumor.
Thus, the prognosis of discordant lymphoma is generally
worse than that for cases of a single lymphoma. Deter-
mining the best therapeutic strategy for treating multiple
lymphomas simultaneously is difficult, and the treatment
strategy typically is commonly based on the more malig-
nant lymphoma type. Fortunately, some target drugs
gene therapy have been reported [19], such as JAK2
selective inhibitor, basing on disease-specific chromo-
some 9p24.1/JAK2 amplification increased JAK2 ex-
pression and activity in bothprimary mediastinal large
B-cell lymphoma and Hodgkin lymphoma. Therefore,
early diagnosis and accurate determination of the
histological types of all tumors are critically important
for individualized treatment and favorable prognosis
of discordant lymphoma.Conclusion
The diagnosis of discordant lymphoma, subsequent differ-
entiation of the involved lymphomas, and eventual treat-
ment planning are challenging due to the complex, highly
variable, and poorly understood pathogenesis of this condi-
tion. Additional research is needed to determine an accur-
ate incidence of discordant lymphoma, given that current
underestimation of this condition may lead to missed diag-
nosis and thus worsen patient outcomes.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.Additional file
Additional file 1: Gene rearrangements and clonality analysis of
immunoglobulin heavy chain gene, Kappa light chain gene, and
Lambda light chain gene were identified in mediastinal large B-cell
lymphoma and in nodular sclerosis Hodgkin lymphoma in the right
supraclavicular lymph nodes using the IdentiCloneTM IGH/IGK/IGL
Gene Clonality Assay (InVivoScribe Technologies, CA, USA).
(TIF 1129 kb)
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